000 01467 a2200469 4500
005 20250513150802.0
264 0 _c19981026
008 199810s 0 0 eng d
022 _a0149-5992
024 7 _a10.2337/diacare.21.8.1371
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDubois-Laforgue, D
245 0 0 _aMutations in HFE, the hemochromatosis candidate gene, in patients with NIDDM.
_h[electronic resource]
260 _bDiabetes care
_cAug 1998
300 _a1371-2 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAmino Acid Substitution
650 0 4 _aAspartic Acid
650 0 4 _aCysteine
650 0 4 _aDiabetes Mellitus, Type 2
_xgenetics
650 0 4 _aHLA Antigens
_xgenetics
650 0 4 _aHemochromatosis
_xgenetics
650 0 4 _aHemochromatosis Protein
650 0 4 _aHistidine
650 0 4 _aHistocompatibility Antigens Class I
_xgenetics
650 0 4 _aHomozygote
650 0 4 _aHumans
650 0 4 _aMajor Histocompatibility Complex
650 0 4 _aMembrane Proteins
650 0 4 _aPoint Mutation
650 0 4 _aReference Values
650 0 4 _aTyrosine
700 1 _aCaillat-Zucman, S
700 1 _aDjilali-Saiah, I
700 1 _aLarger, E
700 1 _aMercadier, A
700 1 _aBoitard, C
700 1 _aBach, J F
700 1 _aTimsit, J
773 0 _tDiabetes care
_gvol. 21
_gno. 8
_gp. 1371-2
856 4 0 _uhttps://doi.org/10.2337/diacare.21.8.1371
_zAvailable from publisher's website
999 _c9668064
_d9668064